XX FIGO World Congress of Gynecology and Obstetrics 2012

Gynuity Health Projects developed, co-organized, and/or sponsored a series of panels and individual presentations during the International Federation of Gynecology and Obstetrics XX World Congress held in Rome, Italy. The topics presented include various aspects of postpartum hemorrhage, medical abortion and postabortion care, as detailed below.

POSTPARTUM HEMORRHAGE

The Global Challenge of PPH and New FIGO Guidelines on the Prevention and Treatment of PPH with Misoprostol
Moderator: Zarko Alfirevic, U of Liverpool

• The Global Challenge of PPH and New FIGO Guidelines on the Prevention and Treatment of PPH with Misoprostol - Prof Sir Sabaratnam Arulkumaran, FIGO
• The World Health Organization Recommendations on PPH - Metin Gülmezoglu, WHO
• Sublingual Misoprostol for Treatment of PPH: Dose and Side Effects - Dr Wilfrido León, Ecuador
• Programmatic Implications of Current Strategies and New Approaches to Integrating Misoprostol for PPH Management -Rasha Dabash, Gynuity Health Projects
• Why Misoprostol Matters: Beverly Winikoff, Gynuity Health Projects

Misoprostol for the Prevention and Treatment of Post-Partum Haemorrhage: Innovative Country Approaches in Low Resource Settings
Moderator: Jeff Smith

• Misoprostol: A Proven Technology for Prevention and Treatment of PPH - Overview of the Clinical Evidence - Jennifer Blum, Gynuity Health Projects
• Scale-up of Misoprostol for PPH Prevention at the Country Level: Nepal - Swaraj Rajbhandari
• Community-Based Use of Misoprostol for PPH Prevention: Snapshot from a Pilot Study in Uganda Documenting Self-Administration of Misoprostol in a Home Delivery Setting - Andrew Weeks, University of Liverpool
• Community-Based Distribution Models for Rolling Out Misoprostol for PPH Prevention: Experience and Lessons Learned from Uganda and Tanzania - Dr. Susan Mukasa, PSI/PACE, Uganda
• Misoprostol for the Treatment of PPH Following its Use for Prevention (Afghanistan & Pakistan) - Shafiq Mirzazada, Aga Khan Health Services, Afghanistan

Individual oral presentations
Relationship between Time to Placental Delivery and Post-Partum Blood Loss - Wendy Sheldon, Gynuity Health Projects

Does the Effect of Oxytocin Prophylaxis on Post-Partum Blood Loss Depend on Route of Administration? - Jill Durocher, Gynuity Health Projects

Effectiveness of the components of active management of the third stage of labor - Wendy Sheldon, Gynuity Health Projects

Route of Administration of Oxytocin in Prevention of Postpartum Hemorrhage - Ilana Dzuba , Gynuity Health Projects

Mapping Misoprostol for PPH: Regional Perspectives on Challenges and Opportunities - Robinson Karuga, Family Care International

MEDICAL ABORTION AND POSTABORTION CARE

Gynuity-sponsored panel: Innovations in medical abortion
Moderator: Paul van Look

• Does route matter? What we know about medical abortion outcomes with regimens using various routes of misoprostol administration - Rasha Dabash, Gynuity Health Projects
• Bridging a Gap in Global Abortion Care: Extending gestational age using medical methods - Ilana Dzuba, Gynuity Health Projects
• Optimizing abortion care in the second trimester: New information on second trimester terminations using mifepristone+misoprostol - Rodica Comendant, Gynuity Health Projects
• Alternative Follow-Up with a Semi-Quantitative Pregnancy Test in International Settings - Nguyen Thi Nhu Ngoc, Gynuity Health Projects
• Putting it all together: What does this mean for Medical Abortion Service Provision in the 21st Century - Beverly Winikoff, Gynuity Health Projects

Gynuity and WomanCare Global sponsored panel: Methods of Assessing Medical Abortion Outcome: High Technology to No Technology
Moderator: Paul Blumenthal, Stanford

• Ultrasound after medical abortion, its uses and limitations - Matt Reeves, Woman Care Global
• R U OK? Using new communication technologies to communicate with women after medical abortion - Patricia Lohr, Bpas
• Results of a study of telephone follow-up to determine outcome of medical abortion - Mary Fjerstad, Woman Care Global
• Using a semi-quantitative pregnancy test to determine medical abortion outcome in in international settings - Jennifer Blum, Gynuity Health Projects
• Client interview and bimanual examination using no technology to assess outcome of medical abortion - Kristina Gemzell, Karolinska Institute

Individual oral presentations
National expansion study of medical abortion to 63 days LMP in Tunisian family planning clinics - Selma Hajri, Tunisia

Outcomes of a double-blind randomized trial comparing misoprostol-only to mifepristone+misoprostol for home-based early medical abortion - Selma Hajri, Tunisia

Acceptability of Home Use of Mifepristone for Medical Abortion - Beverly Winikoff, Gynuity Health Projects

Introduction of Misoprostol as First Line Treatment of Incomplete Abortion: The Senegal Experience - Ayisha Diop, Gynuity Health Projects